0
Signin
countryflagCA

888-969-2592

RY 144.17 0.4529% TD 77.39 0.0517% SHOP 78.87 -1.3878% CNR 171.64 0.5625% ENB 50.09 -0.4769% CP 110.62 0.6277% BMO 128.85 -0.548% TRI 233.58 1.1563% CNQ 103.29 -0.174% BN 60.87 -0.2295% ATD 75.6 -1.447% CSU 3697.0 1.1582% BNS 65.76 -0.3485% CM 66.6 -0.5525% SU 54.21 1.1569% TRP 53.15 0.3398% NGT 58.54 -0.3405% WCN 226.5 0.4123% MFC 35.905 0.9986% BCE 46.75 -0.5954%

MedX Health Corp

Healthcare CA MDX

0.08CAD
-(-%)

Last update at 2024-05-16T18:46:00Z

Day Range

0.080.08
LowHigh

52 Week Range

0.040.09
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -5.13370M -5.32354M -3.19948M -3.27635M -4.18657M
Minority interest - - - - -
Net income -5.13370M -5.32354M -3.19948M -3.27635M -4.18657M
Selling general administrative 2.94M 3.55M 2.79M 2.94M 3.80M
Selling and marketing expenses - - - - -
Gross profit 0.24M 0.29M 0.27M 0.48M 0.69M
Reconciled depreciation 0.05M 0.05M 0.08M 0.14M 0.10M
Ebit - - -3.02942M -3.13044M -4.08479M
Ebitda -3.81329M -4.49412M -3.06185M -3.01507M -3.98387M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -3.86838M -4.56275M -3.02942M -3.13044M -4.08479M
Other operating expenses - - - - -
Interest expense 1.27M 0.78M 0.06M 0.13M 0.10M
Tax provision - - - - -
Interest income - - - - -
Net interest income -1.26872M -0.77761M -0.05817M -0.12503M -0.10189M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.51M 0.56M 0.53M 0.86M 1.09M
Total operating expenses 4.38M 5.13M 3.56M 3.99M 5.17M
Cost of revenue 0.27M 0.27M 0.26M 0.38M 0.40M
Total other income expense net 0.00340M 0.02M -0.11188M -0.02088M 0.00010M
Discontinued operations - - - - -
Net income from continuing ops -5.13370M -5.32354M -3.19948M -3.27635M -4.18657M
Net income applicable to common shares - - -3.19948M -3.27635M -4.18657M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 0.68M 0.73M 0.73M 0.44M 0.65M
Intangible assets - - - 0.03M 0.12M
Earning assets - - - - -
Other current assets - - - - -
Total liab 7.76M 4.36M 2.80M 3.30M 2.20M
Total stockholder equity -7.08098M -3.63042M -2.07011M -2.86691M -1.54435M
Deferred long term liab - - - - -
Other current liab - 0.62M 0.59M 0.62M 0.59M
Common stock - - 23.00M 20.29M 19.45M
Capital stock 23.96M 23.94M 23.00M 20.29M 0.00000M
Retained earnings -46.26918M -41.13548M -35.81194M -32.61246M -29.33611M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.14M 0.11M 0.04M 0.01M 0.04M
Cash and equivalents - - - - -
Total current liabilities 6.88M 1.97M 2.57M 3.30M 2.20M
Current deferred revenue - - - - -
Net debt 4.86M 2.47M 0.88M 0.74M 0.50M
Short term debt - - - - 0.53M
Short long term debt 4.12M 0.19M 0.68M 0.75M 0.53M
Short long term debt total - - - - -
Other stockholder equity - - 2.41M 2.21M 2.36M
Property plant equipment - - 0.22M 0.06M 0.04M
Total current assets 0.54M 0.54M 0.51M 0.35M 0.50M
Long term investments - - - - -
Net tangible assets - - -2.07011M -2.89540M -1.66303M
Short term investments - - - - -
Net receivables 0.00820M 0.00963M 0.04M 0.05M 0.14M
Long term debt 0.88M 2.39M 0.23M - -
Inventory 0.38M 0.37M 0.37M 0.24M 0.28M
Accounts payable 0.62M 0.50M 0.56M 1.09M 0.40M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 0.16M
Deferred long term asset charges - - - - -
Non current assets total 0.14M 0.19M 0.22M 0.08M 0.16M
Capital lease obligations - - 0.03M 0.03M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M -0.01649M -0.00550M -0.00444M -0.01085M
Change to liabilities - 0.00000M -0.12661M 0.86M 0.25M
Total cashflows from investing activities - - -0.00550M -0.00444M -0.01085M
Net borrowings - - -0.04364M 0.12M -0.24642M
Total cash from financing activities 2.84M 4.60M 2.94M 1.30M 2.56M
Change to operating activities - - -0.00936M -0.01312M 0.03M
Net income -5.13370M -5.32354M -3.19948M -3.27635M -4.18657M
Change in cash 0.04M 0.07M 0.03M -0.02702M -0.05731M
Begin period cash flow 0.11M 0.04M 0.01M 0.04M 0.10M
End period cash flow 0.14M 0.11M 0.04M 0.01M 0.04M
Total cash from operating activities -2.80084M -4.51671M -2.90887M -1.32479M -2.60654M
Issuance of capital stock 0.00000M 0.93M 2.98M 1.18M 2.06M
Depreciation 0.05M 0.05M 0.08M 0.14M 0.10M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -0.00567M 0.00055M -0.13379M 0.04M -0.13419M
Change to account receivables -0.13444M -0.03130M 0.02M 0.13M -0.10635M
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.22M 0.22M 0.35M 0.35M
Change to netincome - - 0.46M 0.79M 1.44M
Capital expenditures 0.00000M 0.02M 0.00550M 0.00444M 0.01M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.02M 0.04M -0.25814M 0.98M 0.04M
Stock based compensation 0.33M 0.23M 0.35M 0.77M -
Other non cash items 1.27M 0.51M 0.02M 0.07M 0.06M
Free cash flow -2.80084M -4.53320M -2.91437M -1.32923M -2.61739M

Fundamentals

  • Previous Close 0.08
  • Market Cap11.79M
  • Volume10000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.40947M
  • Revenue TTM0.60M
  • Revenue Per Share TTM0.003
  • Gross Profit TTM 0.27M
  • Diluted EPS TTM-0.03

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MDX
MedX Health Corp		 - -% 0.08 - 23.98 19.56 - 31.11 -5.7851
PINK
Perimeter Medical Imaging AI Inc		 -0.01 1.75% 0.56 - - 117.72 2.89 122.12 -4.2252
VPT
VentriPoint Diagnostics Ltd		 -0.005 2.22% 0.22 - - 1376.49 34.01 1193.16 -9.1712
TLT
Theralase Technologies Inc.		 -0.005 3.03% 0.16 - - 35.41 23.10 36.69 -9.1528
ASG
Aurora Spine Corp		 0.01 3.77% 0.28 - - 1.83 5.11 2.14 -31.4665

Reports Covered

Stock Research & News

View All

Profile

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.

MedX Health Corp

1495 Bonhill Road, Mississauga, ON, Canada, L5T 1M2

Key Executives

Name Title Year Born
Mr. Louie Canitano COO & MD of Light Therapy Products NA
Mr. Michael Druhan Pres of Dermatological Services & Products NA
Mr. Naman Demaghlatrous BAMA Pres, CEO & Director NA
C H Freeman Interim Chief Financial Officer NA
Mr. Paul Karam Sales and Marketing Director of Europe, Middle East & Africa NA
Dr. Daniel A. Kaute Managing Director of Europe NA
Mr. Scott Naughton Managing Director of US Operations NA
Mr. Christopher H. Freeman Sec. NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).